ArticleResearch square2025
Training Set Augmentation and Harmonization Enables Radiomic Models to Detect Early Onset of Lung Cancer.
Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
7 authors.
Funding
Abstract
Radiomics-based machine learning models have the potential to detect lung cancer at inception from CT scans and transform patient outcomes. Low malignancy rates in early-development pulmonary nodules (PNs) and variable image acquisition hinder development of clinically applicable radiomics-based early detection models. To address these challenges, we augmented training using later-development PNs and harmonized for acquisition effects. We first trained machine learning models to predict PN malignancy using radiomic features from scans of early-development benign and malignant PNs (n = 187) harmonized using ComBat. Observing near-chance performance, we augmented training with later-development benign and malignant PNs (n = 225). We evaluated whether harmonization must incorporate biological differences that impact acquisition effects in added training data. To correct features for variability in four acquisition parameters, we compared: 1) harmonization without biological distinction, 2) harmonizing with a covariate distinguishing early-development, benign augmentation, malignant augmentation training datasets, 3) harmonizing each dataset separately. Models trained using augmented data harmonized without biological distinction failed to improve. Models trained on augmented data harmonized with a covariate (ROC-AUC 0.72 [0.67-0.76]) or separately (ROC-AUC 0.69 [0.63-0.74]) achieved significantly higher test ROC-AUC (Delong test, adjusted p ≤ 0.05). Our findings lay groundwork for clinically viable radiomics tools harnessing routine screening imaging for lung cancer early detection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.